Cardiotoxicity as undesired side effect in the treatment of breast cancer
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Improvement of methods used in breast cancer therapy resulted in increased treatment effectiveness and prolonged survival of patients. However, this is accompanied by increased frequency of adverse side effects, including cardiac toxicity, which is becoming a serious problem affecting the quality of life and overall survival of cancer patients. The risk of developing cardiovascular complications depends on the type and dose of therapeutic agent used. The highest risk of cardiotoxicity is associated with anthracyclines. They are used frequently in cancer therapy due to their high efficiency but show a dose-dependent toxicity to the cardiovascular system. Cardiotoxicity can also occur with other substances used in breast cancer chemotherapy, as well as with radiotherapy. Combining potentially cardiotoxic therapeutic agents, commonly used in combination therapy, may result in escalation of toxic side effects. Mechanisms of heart damage are different for various cardiotoxic agents, but symptoms usually involve heart failure, ischemic heart disease, arrhythmias, hypertension, valvular diseases or pericarditis and myocarditis. The practices used to reduce the risk of cardiotoxic effects of cancer therapy include evaluation of cardiac functions before treatment and constant monitoring during and after treatment. Furthermore, limited doses and modifications of anticancer agent administration patterns are employed, as well as simultaneous application of cardioprotective agents. Understanding of cardiotoxic mechanisms of agents used in breast cancer treatment can help to develop efficient cardioprotective substances. Because oxidative stress plays an important role in the toxicity of cancer therapy, compounds with antioxidant properties are a very promising target of research.
Authors and Affiliations
Michalina Gramatyka
Keywords
Related Articles
- EP ID EP67357
- DOI -
- Views 161
- Downloads 0
Biologiczne skutki stresu oksydacyjnego wywołanego działaniem pestycydów
Pestycydy są powszechnie stosowane do ochrony roślin, produktów roślinnych, a także są wykorzystywane w wielu gałęziach przemysłu. Zaliczane są do związków szkodliwych. Mimo istniejących rygorystycznych kontroli ich st...
Efflux-mediated antimicrobial multidrug resistance
Multidrug resistance is a major problem in the treatment of infectious diseases caused by bacteria and fungi. One of the basic mechanisms of resistance is active efflux of distinct drugs from cells. Export of toxic com...
The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase*
Paraoxonase 1 ([i]PON1[/i]) is a member of a three-gene family ([i]PON1, PON2[/i], and [i]PON3[/i]). PON1 activity dominates in human plasma. It is secreted from hepatic cells and is found in the circulation bound to hig...
Komórka na granicy życia i śmierci, czyli oddziaływania między procesami autofagii i apoptozy
Przez ostatnie kilkanaście lat zależności między autofagią i apoptozą były przedmiotem intensywnych badań. Zaburzenia każdego z tych procesów zaangażowane są w etiologię licznych chorób. Wpływ autofagii i apoptozy na fun...
The impact of IL18 gene polymorphisms on mRNA levels and interleukin-18 release by peripheral blood mononuclear cells
Introduction: Interleukin-18 (IL-18) is a pleiotropic cytokine playing an important role as a modulator of immune responses, found to play a role in pathogenesis of numerous inflammatory-associated disorders. In the pre...